Sep 21–27, 2026 · 4 new studies, 1 review · Orthopaedic Oncology archive · All weeks
The new Orthopaedic Oncology research The Reduction sent the week of Sep 21–27, 2026, with the week’s most recent reviews, each with a one-line summary.
Get papers like these by email, free: subscribe to The Reduction, focused on your interests, on the days you pick.
This report reviews sarcoma disease burden, resource constraints, and innovative limb-salvage strategies in India and Asia, calling for policy and training improvements to close care gaps.
In pediatric osteosarcoma patients, the Area Deprivation Index—unlike other social determinants of health measures—identified significant disparities in presentation delay, local recurrence, and overall survival.
In cell and mouse models, pulsed electromagnetic fields killed osteosarcoma cells via ferroptosis while promoting normal bone healing, suggesting a noninvasive adjuvant therapy after tumor resection.
In this Danish cohort of 281 patients with proximal femur metastases, endoprosthetic reconstruction had lower implant failure and better overall survival than osteosynthesis, though revision rates were similar.
This review and single-institution case series discusses surgical management strategies for symptomatic, aggressive vertebral hemangiomas and proposes a treatment algorithm incorporating embolization, radiotherapy, and vertebroplasty.
Home · All weeks · Archive · Subscribe · FAQ
© 2026 The Reduction